Voglio sapere a riguardo di…

7092

Federal Register / Vol. 86, No. 15 / Tuesday, January 26, 2021 / Notices
FEDERAL RESERVE SYSTEM

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 12 U.S.C. 1841 et seq.
BHC Act, Regulation Y 12 CFR part 225, and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below.
The public portions of the applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Banks indicated below and at the offices of the Board of Governors.
This information may also be obtained on an expedited basis, upon request, by contacting the appropriate Federal Reserve Bank and from the Boards Freedom of Information Office at https www.federalreserve.gov/foia/
request.htm. Interested persons may express their views in writing on the standards enumerated in the BHC Act 12 U.S.C. 1842c.
Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington DC 205510001, not later than February 25, 2021.
A. Federal Reserve Bank of San Francisco Sebastian Astrada, Director, Applications 101 Market Street, San Francisco, California 941051579: 1. St.
Laurent Investments LLC, Vancouver, Washington; to become a bank holding company by acquiring Peoples Bank of Commerce, Medford, Oregon.
Board of Governors of the Federal Reserve System, January 21, 2021.
Michele Taylor Fennell, Deputy Associate Secretary of the Board.
FR Doc. 202101690 Filed 12521; 8:45 am BILLING CODE P

VerDate Sep<11>2014

20:59 Jan 25, 2021

Jkt 253001

Centers for Disease Control and Prevention 30Day210728

Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention CDC
has submitted the information collection request titled National Notifiable Diseases Surveillance System NNDSS to the Office of Management and Budget OMB for review and approval. CDC previously published a Proposed Data Collection Submitted for Public Comment and Recommendations notice on October 23, 2020 to obtain comments from the public and affected agencies. CDC did not receive comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information collection project.
The Office of Management and Budget is particularly interested in comments that:
a Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;
b Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;
c Enhance the quality, utility, and clarity of the information to be collected;
d Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and e Assess information collection costs.
To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call 404 6397570.
Comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular information collection by selecting Currently under 30-day ReviewOpen
PO 00000

Frm 00033

Fmt 4703

Sfmt 4703

for Public Comments or by using the search function. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to 202 3955806. Provide written comments within 30 days of notice publication.
Proposed Project National Notifiable Diseases Surveillance System NNDSS 0920
0728, Exp. 4/30/23RevisionCenter for Surveillance, Epidemiology and Laboratory Services CSELS, Centers for Disease Control and Prevention CDC.
Background and Brief Description The Public Health Services Act 42
U.S.C. 241 authorizes CDC to disseminate nationally notifiable condition information. The National Notifiable Diseases Surveillance System NNDSS is based on data collected at the state, territorial and local levels as a result of legislation and regulations in those jurisdictions that require health care providers, medical laboratories, and other entities to submit healthrelated data on reportable conditions to public health departments. These reportable conditions, which include infectious and non-infectious diseases, vary by jurisdiction depending upon each jurisdictions health priorities and needs. Each year, the Council of State and Territorial Epidemiologists CSTE, supported by CDC, determines which reportable conditions should be designated nationally notifiable or under standardized surveillance.
CDC requests a three-year approval for a Revision for the NNDSS, OMB
Control No. 09200728, Expiration Date 04/30/2023. This Revision includes requests for approval to: 1 Receive case notification data for Multisystem Inflammatory Syndrome MIS
associated with Coronavirus Disease 2019 COVID19; 2 receive new disease-specific data elements for Anthrax, Brucellosis, Campylobacteriosis, Cholera, Cryptosporidiosis, Hansens Disease, Leptospirosis, Melioidosis, MIS
associated with COVID19, COVID19, S. Paratyphi Infection, S. Typhi Infection, Salmonellosis, STEC, Shigellosis, and Vibriosis; and 3
Receive new vaccine-related data elements for all conditions.
The NNDSS currently facilitates the submission and aggregation of case notification data voluntarily submitted to CDC from 60 jurisdictions: Public health departments in every U.S. state, New York City, Washington DC, five
E:FRFM26JAN1.SGM

26JAN1